Cannabis and Pelvic Pain
Survey data shows relief; controlled trials are sparse. Here's what the evidence actually says.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
Many people with endometriosis and period pain report cannabis helps. But almost all that evidence is people filling out surveys saying 'yes, I feel better'—not controlled trials. One small randomized trial supports short-term pain relief. The real gap: we don't know the best dose, how it stacks up against NSAIDs long-term, or whether it actually changes disease. It's a reasonable option for refractory pain, not a replacement for proven treatments.
Not Medical Advice
This article is not medical advice. It summarizes published evidence and survey data to help you understand what is and is not known. Pelvic pain has many causes—endometriosis, adenomyosis, fibroids, interstitial cystitis, pelvic floor dysfunction, nerve entrapment, cancer, infection—and several are serious and treatable. If you have new, severe, or worsening pelvic pain, see a clinician before self-treating with cannabis or anything else. Cannabis interacts with hormonal contraceptives and other medications and is not appropriate for everyone, especially during pregnancy.
Plain-Language Summary
Pelvic pain is a broad category that includes period pain (dysmenorrhea), endometriosis, vulvodynia, bladder pain syndrome, and chronic pelvic pain of unclear cause. Standard treatments—NSAIDs, hormonal therapies, neuromodulators, physical therapy, surgery—work well for some people and poorly for others.
A growing number of patients use cannabis for pelvic pain, and surveys consistently show most users report meaningful relief [1][2][3]. The catch: surveys ask people who already use cannabis whether they think it helps. That's useful signal, but it's not proof of causation or superiority. Rigorous controlled trials comparing cannabis to placebo or standard treatments in pelvic pain are nearly nonexistent. One small randomized trial in chronic pelvic pain found vaporized cannabis reduced pain compared to placebo [4]. That is the highest-quality evidence we have for pelvic pain specifically.
So cannabis is a reasonable thing to try for refractory pelvic pain—especially when standard options have failed or are not tolerated—but the evidence base is much thinner than patient enthusiasm suggests.
What Probably Works
Short-term pain relief in chronic pelvic pain. A randomized, double-blind, placebo-controlled crossover trial in women with chronic pelvic pain found vaporized THC-dominant cannabis reduced pain intensity versus placebo over a single dosing session Weak / limited[4]. This is the strongest pelvic-pain-specific trial published to date, but it is small and assessed only acute dosing, not chronic use.
Pain and sleep in endometriosis (self-reported). Multiple surveys—including a large Australian cohort of 252 women with endometriosis [1] and a New Zealand survey of 252 women [2]—report that roughly 60–95% of cannabis-using endometriosis patients rate it 'effective' for pain, sleep, nausea, and mood Weak / limited. People often report reducing their use of other pain medications, though this displacement has not been proven in randomized trials.
General chronic non-cancer pain. The 2017 National Academies report found 'substantial evidence' that cannabis is effective for chronic pain in adults Strong evidence[5]. Pelvic pain conditions were not analyzed separately, but it is reasonable to expect the class effect may apply to pelvic pain that is refractory to first-line treatments.
What Might Work
Dysmenorrhea (period pain). Survey data from a U.S. cohort suggests cannabis users find it helpful for menstrual pain, with reported use increasing after legalization Weak / limited[3]. No controlled trials have compared cannabis to NSAIDs or placebo for dysmenorrhea. Historical use in 19th-century Western medicine (cannabis tinctures were listed in the Merck Manual for dysmenorrhea) is interesting context Anecdote[6] but does not establish modern efficacy.
Pelvic floor muscle spasm and hypertonicity. THC has well-documented antispasticity effects in multiple sclerosis Strong evidence[5]. Whether this mechanism translates to pelvic floor dysfunction, myofascial pelvic pain, or vaginismus is biologically plausible but entirely unstudied No data in controlled settings.
Topical and vaginal cannabinoid products. A booming consumer market with almost no controlled human data. One small open-label study of CBD vaginal suppositories in endometriosis showed self-reported pain improvement Weak / limited, but without a placebo arm this tells us very little about true efficacy. Vaginal and rectal absorption of cannabinoids is poorly characterized, and it is unclear whether topical dosing achieves clinically meaningful systemic or local drug levels.
What Does Not Work or Has Weak Evidence
CBD-only products for moderate-to-severe pelvic pain. Survey respondents who used THC-containing products generally reported higher rates of relief than users of CBD-only products Weak / limited[1]. Isolated CBD at typical consumer doses (10–50 mg) has not shown convincing analgesic effects in controlled pain trials Disputed.
Cannabis as a disease-modifying treatment for endometriosis. There is no clinical evidence that cannabis shrinks endometriotic lesions, suppresses lesion growth, or alters disease progression in humans No data. Mouse and cell culture studies show cannabinoid receptors are expressed in endometrial tissue and may modulate inflammation [7], but this preclinical work does not translate to clinical claims about disease modification.
'Indica for pain, sativa for energy.' This is marketing folklore rather than a clinically useful distinction Disputed. The ratio of THC, CBD, and terpenes (chemotype) matters far more than the indica/sativa classification, which is unreliable and not predictive of effects.
What We Don't Know
- Optimal dose, route of administration (inhaled, oral, topical), and cannabinoid ratio for any specific pelvic pain condition.
- Whether daily or chronic cannabis use prevents pain flares or only treats acute pain.
- Long-term safety profile of chronic cannabis use in patients with endometriosis or other chronic pelvic pain (most safety data comes from general adult populations, not gynecologic cohorts).
- Whether vaginal, rectal, or topical cannabinoid products actually deliver clinically meaningful drug levels to target tissues.
- Specific interactions between cannabis and hormonal contraceptives, GnRH agonists (leuprolide, goserelin), or progestins used for endometriosis.
- Effects on fertility and pregnancy outcomes—relevant because many pelvic pain patients are of reproductive age or actively trying to conceive Disputed[8].
Comparison With Standard Treatments
NSAIDs (ibuprofen, naproxen, mefenamic acid). First-line treatment for dysmenorrhea and mild-to-moderate endometriosis pain. Well-studied, inexpensive, and effective for many patients. Cannabis has not been shown to outperform NSAIDs and should not replace them as a first-line option Strong evidence[9]. For patients who do not tolerate NSAIDs (renal disease, GI bleeding risk, allergy), cannabis may be an alternative.
Hormonal therapy (combined oral contraceptives, progestins, GnRH agonists). Can suppress ovulation and endometrial proliferation, reducing endometriosis lesion growth and pain. These are disease-modifying agents in a way cannabis is not. Side effect profiles differ—some patients tolerate one and not the other. Cannabis does not replace hormonal therapy for confirmed endometriosis.
Surgery (laparoscopic excision or ablation). Can provide durable pain relief for endometriosis when lesions are visually identified and removed. Cannabis is not a substitute for surgical management of confirmed lesions causing organ dysfunction or severe pain.
Pelvic floor physical therapy. Strong evidence supports manual therapy and pelvic floor rehabilitation for myofascial pelvic pain, vaginismus, and vulvodynia Strong evidence. Cannabis may complement but does not replace structured physical therapy.
Opioids. Surveys suggest many cannabis users reduce opioid use for pain Weak / limited[1]. This is one of the more interesting potential benefits, given the opioid addiction and overdose crisis. However, the magnitude and causality of this displacement effect have not been proven in randomized trials. Mixing cannabis and opioids increases overdose risk.
Risks and Practical Considerations
- Pregnancy and lactation. Avoid cannabis entirely during pregnancy. Cannabis use in pregnancy is associated with lower birth weight and possible neurodevelopmental effects in offspring Strong evidence[10]. Many pelvic pain patients are of reproductive age or planning pregnancy—this is a critical consideration.
- Cannabinoid hyperemesis syndrome (CHS). Chronic heavy THC use can cause cyclic nausea, vomiting, and severe abdominal pain that mimics a pelvic pain flare or emergency abdominal pathology. This typically resolves within days to weeks after stopping cannabis.
- Cannabis use disorder (dependence). Roughly 1 in 10 adult users and up to 1 in 6 daily users develop cannabis use disorder Strong evidence[5]. Higher risk with early-age onset and daily use. Withdrawal symptoms (anxiety, insomnia, irritability) can occur after regular use.
- Cognitive and driving impairment. THC-containing products impair attention, memory, and reaction time for several hours after use. Do not drive or operate machinery while impaired.
- Drug interactions. CBD is a potent inhibitor of CYP3A4 and CYP2C9 enzymes and can raise levels of some medications (immunosuppressants, statins, anticoagulants). See Cannabis and Polypharmacy Risks.
- Cost and access. Medical cannabis is rarely covered by insurance. Out-of-pocket costs often exceed standard treatments. Legal status varies by jurisdiction.
- Discuss your gynecologic diagnosis, other medications, and reproductive plans with a clinician familiar with both your condition and cannabis.
Sources
- Peer-reviewed Sinclair J, Smith CA, Abbott J, Chalmers KJ, Pate DW, Armour M. Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey. J Obstet Gynaecol Can. 2020;42(3):256-261.
- Peer-reviewed Armour M, Sinclair J, Noller G, et al. Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey. J Womens Health. 2021;30(10):1485-1492.
- Peer-reviewed Han L, Casey BR, Boyd NS, Sridhar A. The Legalization of Cannabis is Associated With a Significant Increase in its Use for the Treatment of Menstrual Pain. J Cannabis Res. 2022;4(1):29.
- Peer-reviewed Reuter SE, Schultz HB, Martin JH, et al. A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of Vaporized Cannabis for Chronic Pelvic Pain. J Pain. 2023;24(7):1195-1205.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Book Russo EB. Cannabis Treatments in Obstetrics and Gynecology: A Historical Review. J Cannabis Therapeutics. 2002;2(3-4):5-35.
- Peer-reviewed Sanchez AM, Vigano P, Mugione A, Panina-Bordignon P, Candiani M. The Molecular Connections Between the Cannabinoid System and Endometriosis. Mol Hum Reprod. 2012;18(12):563-571.
- Peer-reviewed du Plessis SS, Agarwal A, Syriac A. Marijuana, Phytocannabinoids, the Endocannabinoid System, and Male Fertility. J Assist Reprod Genet. 2015;32(11):1575-1588.
- Peer-reviewed Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal Anti-Inflammatory Drugs for Dysmenorrhoea. Cochrane Database Syst Rev. 2015;(7):CD001751.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstet Gynecol. 2017;130(4):e205-e209.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Chronic Pain — Evidence summary of cannabis for chronic pain: modest benefit for some, real risks, and ho...
- Cannabis and Endometriosis Pain — Patient surveys suggest symptom relief, but no clinical trials exist yet.
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis Withdrawal and Sleep Disruption — Sleep disruption is a hallmark of cannabis withdrawal syndrome and typically resolves with...
- Why Edibles Hit Different — How first-pass metabolism and 11-hydroxy-THC make oral cannabis distinct from inhalation.